Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON33289Active, not recruiting
Open-label, single-arm trial of propofol and remifentanil, sponsored by University Medical Center Groningen. Primary endpoints: Change in BIS after standardized pain stimulus, Change in CVI after standardized pain stimulus and 1 more. Started Jul 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON33289.